BUSINESS

`Indian pharma resilient to potential US tariffs'

India Ratings and Research (Ind-Ra) anticipates minimal credit profile impact on Indian pharma companies from potential US tariffs on pharmaceutical imports. While the US accounts for a significant portion of revenue for these companies, its contribution has been declining.

TIMES OF INDIA
2 hours ago
Read Full Article

MORE TO CATCH UP

BUSINESS

Aviation deal: Korea Air seals record $50 billion deal; Boeing and GE secure mega orders

Korean Air has announced a record-breaking $50 billion order for 103 Boeing aircraft and GE Aerospace engines, coinciding with South Korean President Lee Jae Myung’s visit to Washington. This purchase, the largest in the carrier’s h ...more

TIMES OF INDIA
1 hour ago
BUSINESS

Banks told to fix PM-Kisan glitches

ECONOMICS TIMES
2 hours ago

Subscribe for latest news updates from NewsFomo

Get over your FOMO of knowing what's happening. Never miss what matters to you!